FDA puts spotlight on compounded drugs, opens educational center
In an aim to improve quality assurance and control of compounded medicine, the US FDA opens a Compounding Quality Center of Excellence.
Archives for January 7, 2020
Lonza and Allevi pool resources for 3D bioprinting
Lonza signs a collaboration deal with Allevi to offer researchers the tools needed for ‘plug-and-play’ bioprinting for drug research.
Charles River closes $380m HemaCare cell therapy takeover
Charles River Laboratories closes $380m takeover of cell therapy specialist HemaCare to expand in fast-growing sector.